MaxCyte Inc.

NASDAQ: MXCT · Real-Time Price · USD
1.37
-0.04 (-2.84%)
At close: Aug 15, 2025, 3:59 PM
1.35
-1.46%
After-hours: Aug 15, 2025, 06:06 PM EDT

MaxCyte Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
8.51M 10.39M 8.69M 8.16M 10.43M 11.34M 15.67M 8M 9.04M 8.58M 12.42M 10.64M 9.61M 11.59M 10.15M 10.14M 7.11M 6.49M
Cost of Revenue
2.6M 1.5M 2.28M 1.93M 2.52M 2.47M 2.64M 793.4K 1.38M 999.8K 1.55M 1.37M 1.12M 1.06M 1.23M 943.8K 784.5K 693.1K
Gross Profit
5.91M 8.89M 6.41M 6.24M 7.91M 8.87M 13.03M 7.21M 7.67M 7.58M 10.88M 9.27M 8.49M 10.52M 8.93M 9.2M 6.32M 5.8M
Operating Income
-14.25M -11.23M -12.9M -14.05M -11.94M -12.24M -8.08M -13.95M -13.07M -13.18M -6.75M -7.71M -8.74M -4.16M -4.96M -2.44M -4.42M -6.37M
Interest Income
1.87M 2.03M 2.3M 2.5M 2.59M 2.75M 2.82M 2.7M 2.56M 2.3M 1.95M 1.39M 478.7K 91.8K 80.8K 51.5K 8.6K 9.8K
Pretax Income
-12.36M -10.26M -10.6M -11.56M -9.38M -9.53M -5.28M -11.25M -10.51M -10.88M -4.81M -6.43M -8.26M -4.07M -4.87M -2.68M -4.42M -7.11M
Net Income
-12.36M -10.26M -10.6M -11.56M -9.38M -9.53M -5.28M -11.25M -10.51M -8.59M -2.87M -6.43M -7.78M -3.98M -4.87M -2.68M -4.42M -7.11M
Selling & General & Admin
13.89M 14.22M 13.68M 13.95M 14.23M 14.44M 15.26M 13.87M 14.1M 13.79M 11.03M 10.95M 12.03M 10.47M 10.06M 8.86M 7.54M 5.79M
Research & Development
6.27M 5.9M 4.61M 5.32M 5.62M 6.68M 5.84M 6.26M 5.66M 6.05M 5.73M 5.33M 4.7M 3.77M 3.38M 2.77M 3.21M 6.08M
Other Expenses
n/a n/a 1.02M 1.02M n/a n/a n/a 239.1M n/a 912.2K 873.3K -116K 497.1K 447.3K 441.9K n/a n/a n/a
Operating Expenses
20.16M 20.13M 18.21M 20.29M 19.85M 21.11M 21.11M 21.16M 20.74M 20.75M 17.63M 16.99M 17.23M 14.68M 13.88M 11.64M 10.74M 12.17M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 10.9K 116K n/a n/a n/a 289K 13.2K 742.3K
Selling & Marketing Expenses
5.79M 5.7M 6.47M 6.21M 6.62M 7.37M 7.2M 7.05M 6.44M 6.3M 5.38M 4.51M 4.93M 3.84M 4.09M 3.21M 2.91M 2.79M
Cost & Expenses
22.76M 21.62M 21.59M 22.22M 22.37M 23.58M 23.74M 21.96M 22.12M 21.75M 19.17M 18.35M 18.35M 15.75M 15.11M 12.58M 11.53M 12.87M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a 1.58B -2.3M -1.94M n/a -478.7K -91.8K n/a n/a 8.6K 9.8K
Shares Outstanding (Basic)
106.4M 105.95M 104.85M 105.11M 104.64M 104.09M 103.7M 103.45M 103.06M 102.85M 102.12M 101.81M 101.43M 101.31M 100.83M 95.66M 84.71M 81M
Shares Outstanding (Diluted)
106.4M 105.95M 104.85M 105.11M 104.64M 104.09M 103.7M 103.45M 103.06M 102.85M 102.12M 101.81M 101.43M 101.31M 100.83M 95.66M 84.71M 81M
EPS (Basic)
-0.12 -0.1 -0.1 -0.11 -0.09 -0.09 -0.05 -0.11 -0.1 -0.08 -0.03 -0.06 -0.08 -0.04 -0.05 -0.03 -0.05 -0.09
EPS (Diluted)
-0.12 -0.1 -0.1 -0.11 -0.09 -0.09 -0.05 -0.11 -0.1 -0.08 -0.03 -0.06 -0.08 -0.04 -0.05 -0.03 -0.05 -0.09
EBITDA
-11.08M -10.17M -11.37M -12.99M -10.89M -11.16M -6.99M -12.87M -9.49M -9.92M -3.89M -6.97M -8.19M -3.67M -4.54M -2.08M -4.08M -6.05M
EBIT
-12.36M -11.23M -12.9M -14.05M -11.97M -12.28M -8.1M -13.95M -13.07M -13.18M -4.8M -7.71M -8.74M -4.16M -4.96M -2.39M -4.41M -6.36M
Depreciation & Amortization
1.28M 1.06M 1.06M 1.07M 1.08M 1.11M 1.1M 1.08M 1.03M 961.7K 919.6K 709.8K 547.6K 487.4K 416.5K 366K 325.5K 315.9K